Corporate clinical nutrition that moves retention, performance and absence. Measured, reported, and built for the 2027 deadline.
Book a 20-minute scoping callHalf your future leaders will go through this. How many have you prepared for?
It is a metabolic and neurological transition that affects cognition, decision-making and energy in your most experienced women. Treated as awareness, it stays unsolved. Treated clinically, it becomes measurable. Your wellbeing budget keeps growing. Your female attrition is not shrinking. The question is what the budget is actually buying.
Structured nutrition intervention for women in transition, delivered to a defined cohort with a clinical baseline and end point.
Evidence-led briefings for execs, boards and all staff on midlife cognitive capacity and retention risk.
Practical guidance for line managers. What to say, what not to say, and where the legal line sits.
Baseline, outcomes and board-ready data. The part most providers quietly skip.
No fixed shelf price, because no two workforces carry the same risk. Each is scoped on the call.
A keynote or leadership briefing plus a manager session. The fastest way to move from awareness to intent.
The clinical intervention. Baseline, delivery and a measured end point for a defined group of women.
Programme, briefings and quarterly board reporting. For organisations treating this as strategy, not a one-off.
Pricing is scoped on the call so it reflects your real exposure. No fabricated figures.
If a symptom were quietly costing you your best people, how would you even know?
We measure the cohort before we touch anything. Symptoms, energy, self-reported performance.
Targeted nutrition intervention delivered over a defined window, with adherence tracked.
Change quantified and handed to you in board-ready form. Anonymised, aggregated, honest.
When your most experienced woman resigns, what reason will she write down, and what will the real one be?